Another place to seek out potentially explosive stocks is in the biotech space. These innovators are working on the ...

Sales of Casgevy, a gene-edited treatment developed with CRISPR Therapeutics, more than tripled compared to the third quarter, a performance analysts saw as a bright spot in Vertex's report.

Researchers developed a CRISPR-based system that spreads through bacterial populations to disable antibiotic resistance genes ...

Oceanic ecosystems are increasingly threatened by global warming, which causes coral bleaching, species migration and, ...

With a shared purpose, we can realize the true promise of CRISPR and improve healthcare, providing hope to more patients with ...

Researchers at Texas A&M are pairing a widely used ingredient with advanced medical technology to develop new treatments for ...

A new CRISPR-powered light sensor can detect the faintest whispers of cancer in a single drop of blood.

A sales partner offered a ray of hope that this company couldn't for itself.

Researchers used CRISPR gene editing to selectively kill cancer cells with amplified oncogenes. In animal and cellular models ...

Nobel laureate Jennifer Doudna, PhD; Matthew Porteus, MD, PhD, and Rodolphe Barrangou, PhD—offer their views on the commercial potential and challenges of genome editing following a rollercoaster 2025 ...

A new highly sensitive light-based sensor can detect extremely low concentrations of cancer biomarkers in the blood.